PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

脊髄性筋萎縮症 に対する ... - TOGETHER IN SMA

Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care 監修：長谷川三希子先生 東京女子医科大学病院リハビリテーション部主任 Mercuri E, et al.: Neuromuscul Disord. …

Fullscreen Download
Loading..

Tags:

  Diagnosis, Muscular, Spinal, Atrophy, Spinal muscular atrophy

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Related documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - …

www.ema.europa.eu

Spinraza is indicated for the treatment of 5q Spinal Muscular Atrophy. 4.2 Posology and method of administration Treatment with Spinraza should only be initiated by a physician with experience in the management of spinal muscular atrophy (SMA). The decision to treat should be based on an individualisedexpert evaluation of the expected benefits of

  Product, Treatment, Summary, Characteristics, Muscular, Spinal, Summary of product characteristics, Atrophy, Spinal muscular atrophy

Investor Update - roche.com

www.roche.com

for neurological disorders, including rare neuromuscular disorders, such as spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). SMA is the leading genetic cause of death in babies. In September, new data showed that pre-symptomatic babies with SMA treated with Evrysdi maintained the ability to swallow. Evrysdi thus demonstrated

  Muscular, Spinal, Roche, Atrophy, Spinal muscular atrophy

Related search queries

SUMMARY OF PRODUCT CHARACTERISTICS, Treatment, Spinal muscular atrophy, Muscular